C
BIOREM Inc.
BIRMF
$1.66
-$0.14-7.78%
C
Hold
4/1/2021Upgraded
BIOREM Inc. (BIRMF) was upgraded to C from C- on 4/1/2021 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 551.87% from $195.5 to $1.27M, earnings per share increased from $0.003 to $0.0168, and total revenue increased 126.1% from $2.69M to $6.09M.
BIOREM Inc. (BIRMF) was upgraded to C from C- on 4/1/2021 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 551.87% from $195.5 to $1.27M, earnings per share increased from $0.003 to $0.0168, and total revenue increased 126.1% from $2.69M to $6.09M.
C
Hold
1/4/2021Upgraded
BIOREM Inc. (BIRMF) was upgraded to C- from D+ on 1/4/2021 due to a major increase in the total return index, volatility index and valuation index.
BIOREM Inc. (BIRMF) was upgraded to C- from D+ on 1/4/2021 due to a major increase in the total return index, volatility index and valuation index.
D
Sell
8/12/2020Upgraded
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 8/12/2020 due to an increase in the efficiency index and solvency index. Total capital increased 5.67% from $8.78M to $9.28M.
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 8/12/2020 due to an increase in the efficiency index and solvency index. Total capital increased 5.67% from $8.78M to $9.28M.
D
Sell
6/3/2020Downgrade
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 6/3/2020 due to a decline in the volatility index, total return index and solvency index.
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 6/3/2020 due to a decline in the volatility index, total return index and solvency index.
D
Sell
5/8/2020Downgrade
BIOREM Inc. (BIRMF) was downgraded to D+ from C on 5/8/2020 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 411.48% from $516.4 to -$1.61M, earnings per share declined from $0.0137 to -$0.0264, and EBIT declined 282% from $513.8 to -$935.1.
BIOREM Inc. (BIRMF) was downgraded to D+ from C on 5/8/2020 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 411.48% from $516.4 to -$1.61M, earnings per share declined from $0.0137 to -$0.0264, and EBIT declined 282% from $513.8 to -$935.1.
C
Hold
4/18/2019Upgraded
BIOREM Inc. (BIRMF) was upgraded to C from C- on 4/18/2019 due to an increase in the volatility index.
BIOREM Inc. (BIRMF) was upgraded to C from C- on 4/18/2019 due to an increase in the volatility index.
C
Hold
4/1/2019Downgrade
BIOREM Inc. (BIRMF) was downgraded to C- from C on 4/1/2019 due to a decline in the total return index and growth index. Operating cash flow declined 187.56% from $44.2 to -$38.7.
BIOREM Inc. (BIRMF) was downgraded to C- from C on 4/1/2019 due to a decline in the total return index and growth index. Operating cash flow declined 187.56% from $44.2 to -$38.7.
C
Hold
8/31/2017Upgraded
BIOREM Inc. (BIRMF) was upgraded to C from C- on 8/31/2017 due to a significant increase in the valuation index, growth index and efficiency index. Total revenue increased 81.13% from $2.33M to $4.22M, and total capital increased 9.03% from $4.02M to $4.38M.
BIOREM Inc. (BIRMF) was upgraded to C from C- on 8/31/2017 due to a significant increase in the valuation index, growth index and efficiency index. Total revenue increased 81.13% from $2.33M to $4.22M, and total capital increased 9.03% from $4.02M to $4.38M.
C
Hold
8/28/2017Upgraded
BIOREM Inc. (BIRMF) was upgraded to C- from D+ on 8/28/2017 due to a substantial increase in the total return index and volatility index.
BIOREM Inc. (BIRMF) was upgraded to C- from D+ on 8/28/2017 due to a substantial increase in the total return index and volatility index.
D
Sell
5/19/2017Upgraded
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 5/19/2017 due to an increase in the growth index, solvency index and volatility index. Operating cash flow increased 980.75% from $168.8 to $1.82M, EBIT increased 114.97% from -$60.8 to $9.1, and debt to equity declined from 0.9 to 0.
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 5/19/2017 due to an increase in the growth index, solvency index and volatility index. Operating cash flow increased 980.75% from $168.8 to $1.82M, EBIT increased 114.97% from -$60.8 to $9.1, and debt to equity declined from 0.9 to 0.
D
Sell
10/18/2016Downgrade
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 10/18/2016 due to a decline in the volatility index and total return index.
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 10/18/2016 due to a decline in the volatility index and total return index.
D
Sell
10/3/2016Upgraded
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 10/3/2016 due to an increase in the volatility index and valuation index.
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 10/3/2016 due to an increase in the volatility index and valuation index.
D
Sell
7/28/2016Downgrade
BIOREM Inc. (BIRMF) was downgraded to D from C- on 7/28/2016 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 207.15% from -$96.5 to -$296.4, earnings per share declined from $0.0073 to -$0.0078, and net income declined 132.15% from $272.5 to -$87.6.
BIOREM Inc. (BIRMF) was downgraded to D from C- on 7/28/2016 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 207.15% from -$96.5 to -$296.4, earnings per share declined from $0.0073 to -$0.0078, and net income declined 132.15% from $272.5 to -$87.6.
C
Hold
6/24/2016Downgrade
BIOREM Inc. (BIRMF) was downgraded to C- from C on 6/24/2016 due to a noticeable decline in the volatility index and total return index.
BIOREM Inc. (BIRMF) was downgraded to C- from C on 6/24/2016 due to a noticeable decline in the volatility index and total return index.
C
Hold
5/20/2016Upgraded
BIOREM Inc. (BIRMF) was upgraded to C from C- on 5/20/2016 due to a substantial increase in the growth index, efficiency index and solvency index. Net income increased 192.07% from $93.3 to $272.5, EBIT increased 135.27% from $194.5 to $457.6, and earnings per share increased from $0.0056 to $0.0073.
BIOREM Inc. (BIRMF) was upgraded to C from C- on 5/20/2016 due to a substantial increase in the growth index, efficiency index and solvency index. Net income increased 192.07% from $93.3 to $272.5, EBIT increased 135.27% from $194.5 to $457.6, and earnings per share increased from $0.0056 to $0.0073.
C
Hold
5/11/2016Upgraded
BIOREM Inc. (BIRMF) was upgraded to C- from D+ on 5/11/2016 due to an increase in the volatility index, growth index and total return index.
BIOREM Inc. (BIRMF) was upgraded to C- from D+ on 5/11/2016 due to an increase in the volatility index, growth index and total return index.
D
Sell
4/8/2016Downgrade
BIOREM Inc. (BIRMF) was downgraded to D+ from C- on 4/8/2016 due to a decline in the volatility index, efficiency index and total return index. Net income declined 61.59% from $242.9 to $93.3, and total capital declined 4.81% from $3.64M to $3.47M.
BIOREM Inc. (BIRMF) was downgraded to D+ from C- on 4/8/2016 due to a decline in the volatility index, efficiency index and total return index. Net income declined 61.59% from $242.9 to $93.3, and total capital declined 4.81% from $3.64M to $3.47M.
C
Hold
3/11/2016Downgrade
BIOREM Inc. (BIRMF) was downgraded to C- from C on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
BIOREM Inc. (BIRMF) was downgraded to C- from C on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
C
Hold
1/19/2016Downgrade
BIOREM Inc. (BIRMF) was downgraded to C from C+ on 1/19/2016 due to a major decline in the growth index, volatility index and efficiency index. Operating cash flow declined 113.36% from $739.3 to -$98.8, net income declined 58.43% from $584.3 to $242.9, and earnings per share declined from $0.0185 to $0.0091.
BIOREM Inc. (BIRMF) was downgraded to C from C+ on 1/19/2016 due to a major decline in the growth index, volatility index and efficiency index. Operating cash flow declined 113.36% from $739.3 to -$98.8, net income declined 58.43% from $584.3 to $242.9, and earnings per share declined from $0.0185 to $0.0091.
C
Hold
10/6/2015Upgraded
BIOREM Inc. (BIRMF) was upgraded to C+ from C on 10/6/2015 due to a noticeable increase in the volatility index and total return index.
BIOREM Inc. (BIRMF) was upgraded to C+ from C on 10/6/2015 due to a noticeable increase in the volatility index and total return index.
C
Hold
9/21/2015Downgrade
BIOREM Inc. (BIRMF) was downgraded to C from C+ on 9/21/2015 due to a decline in the valuation index.
BIOREM Inc. (BIRMF) was downgraded to C from C+ on 9/21/2015 due to a decline in the valuation index.
C
Hold
9/4/2015Upgraded
BIOREM Inc. (BIRMF) was upgraded to C+ from C on 9/4/2015 due to an increase in the volatility index, growth index and solvency index.
BIOREM Inc. (BIRMF) was upgraded to C+ from C on 9/4/2015 due to an increase in the volatility index, growth index and solvency index.
C
Hold
8/28/2015Upgraded
BIOREM Inc. (BIRMF) was upgraded to C from D on 8/28/2015 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 364.38% from $159.2 to $739.3, EBIT increased 41.03% from $483.5 to $681.9, and net income increased 37.26% from $425.7 to $584.3.
BIOREM Inc. (BIRMF) was upgraded to C from D on 8/28/2015 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 364.38% from $159.2 to $739.3, EBIT increased 41.03% from $483.5 to $681.9, and net income increased 37.26% from $425.7 to $584.3.
D
Sell
7/28/2015Downgrade
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 7/28/2015 due to a large decline in the volatility index and total return index.
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 7/28/2015 due to a large decline in the volatility index and total return index.
D
Sell
6/3/2015Upgraded
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 6/3/2015 due to a large increase in the efficiency index. Total capital increased 8.52% from $2.83M to $3.07M.
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 6/3/2015 due to a large increase in the efficiency index. Total capital increased 8.52% from $2.83M to $3.07M.
D
Sell
8/27/2014Downgrade
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 8/27/2014 due to a large decline in the efficiency index and total return index. Total capital declined 18.83% from $3.68M to $2.99M.
BIOREM Inc. (BIRMF) was downgraded to D from D+ on 8/27/2014 due to a large decline in the efficiency index and total return index. Total capital declined 18.83% from $3.68M to $2.99M.
D
Sell
7/1/2014Upgraded
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 7/1/2014 due to a major increase in the volatility index and total return index.
BIOREM Inc. (BIRMF) was upgraded to D+ from D on 7/1/2014 due to a major increase in the volatility index and total return index.
OTC PK
03/14/2025 1:29PM Eastern
Quotes delayed
